Publications View

Pub ID 1206
Publication Title Combination therapy with bioengineered miR-34a prodrug and doxorubicin synergistically suppresses osteosarcoma growth
DOI https://doi.org/10.1016/j.bcp.2015.10.015
PMID 0
Year 2015

Cell line and drug 2

miRNA ID
Trait, Trait subtype
Cell Line
Drug 1
Drug 2
Drug 3
 
MI0000268 Osteosarcoma (OS), "" Parent MG-63 Doxorubicin Not Applicable Not Applicable
MI0000268 Osteosarcoma (OS), "" Parent 143B Doxorubicin Not Applicable Not Applicable